2012•Digestive and Liver DiseaseRequires access

P.16.22 INFLIXIMAB AS RESCUE THERAPY FOR PATIENTS WITH SEVERE ULCERATIVE COLITIS REFRACTORY TO SYSTEMIC CORTICOSTEROIDS: A SINGLE CENTRE OPEN-LABEL STUDY

Małgorzata Fortuna, Renzo Montanari, Andrea Geccherle, Arianna Sartori, Giacomo Ruffo, Maria Chiaramonte

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Rescue therapy, Infliximab, Ulcerative colitis, Refractory (planetary science), Open label, Internal medicine, Tumor necrosis factor alpha

Back to paper search Browse research topics Original source

P.16.22 INFLIXIMAB AS RESCUE THERAPY FOR PATIENTS WITH SEVERE ULCERATIVE COLITIS REFRACTORY TO SYSTEMIC CORTICOSTEROIDS: A SINGLE CENTRE OPEN-LABEL STUDY — Research Paper | ScholarLens